Clinical Trial Update: Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of RAD001 (everolimus) and AMG479 (ramucirumab) in patients with advanced solid tumors. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AMG479 (Ramucirumab)
• RAD001 (everolimus)

Snippet

Sponsor: Shadia Jalal | Conditions: Neoplasm Metastases | Phase 1 | Status: COMPLETED